Presentation is loading. Please wait.

Presentation is loading. Please wait.

IMPROVING THE USE OF PSYCHOTROPIC MEDICATIONS IN CHILDREN AND YOUTH IN FOSTER CARE Oregon CHCS team Advisory Committee June 15, 2013.

Similar presentations


Presentation on theme: "IMPROVING THE USE OF PSYCHOTROPIC MEDICATIONS IN CHILDREN AND YOUTH IN FOSTER CARE Oregon CHCS team Advisory Committee June 15, 2013."— Presentation transcript:

1 IMPROVING THE USE OF PSYCHOTROPIC MEDICATIONS IN CHILDREN AND YOUTH IN FOSTER CARE Oregon CHCS team Advisory Committee June 15, 2013

2 PROPOSED STRATEGIES AND NEXT STEPS ► INFORMATION ► CONSENT ► CLINICAL PRACTICE

3 Information ► Youth in foster care (YOUTH ADVOCACY GROUPS)  What to expect in foster care and rights ► Need a pamphlet to adopt ► Need a method to distribute and help comprehend with a supportive adult (or peer for older youth).  Review of Psychiatric Medications ► Alternatives to guide to healthy choices pamphlet ► Need a method to distribute and help comprehend with a supportive adult (or peer for older youth).

4 Information ► Foster Parents:  Trauma training ► Involve the AMH trauma sub committee ► Involve PSU training  Establish a curriculum  Establish a method of consistent training  CPS training ► Work with OHSU CPS advisory committee to develop curriculum and strategy for implementation  Medication / health care training ► In place, need to improve process and materials

5 Information ► DHS Staff  Trauma training ► Involve the AMH trauma sub committee ► Involve PSU training  Establish a curriculum  Establish a method of consistent training  CPS training ► Work with OHSU CPS advisory committee to develop curriculum and strategy for implementation  Medication / health care training ► In place, need to improve process and materials ► Implement consultation and second opinion strategies.

6 Information ► Providers: ► Dashboards ► Trauma informed clinics and clinicians  AMH trauma sub committee ► Evidence Based Guidelines  OPAL K guidelines reviewed by OCCAP  Process for provider buy-in  Data can help providers manage their programs

7 Consent ► Current :  Clinician PARC (informs) with child and possibly the caregiver  Clinician fax form 173C to DHS  Caregiver notifies caseworker of prescription  Caseworker reviews information with supervisor to authorize beginning of medication ► Proposed new process  Clinician PARC (informs) with child and caregiver  Caregiver provides information to caseworker/supervisor (verbal and written 173C)  Supervisor and caseworker reviews information (department protocols)  Caseworker notifies caregiver when and if to proceed with medication regime Subject to Legal review

8 Clinical Practice ► Disseminate Prescribing Flags  Poly pharmacy greater than 4  Medication without an assessment  Medication without a diagnosis  Medication for children under six  Antipsychotics ► Under six ► Multiple ► Longer than 6 months without a diagnosis

9 Clinical Practice ► Oversight  Initiate a process for oversight of requests for new antipsychotic for any child and any psychotropic for a child under the age of 6 ► Initiate a process for providing and receiving feedback  Dashboards to providers  Dashboards to CCOs TED  When flags triggered ► Communicate with provider ► Peer review through DHS MD or via OPAL K

10 Next Steps ► Training and education workgroup Treatment of Aggression workgroup ► Legal and practical review of consent process ► Trauma training: coordination with CSAC Trauma Committee initiatives. PSU foster parent training program ► Building CPS capacity to serve Foster families ► Building connections with CCOs ► What happens if OPAL K is a no go?


Download ppt "IMPROVING THE USE OF PSYCHOTROPIC MEDICATIONS IN CHILDREN AND YOUTH IN FOSTER CARE Oregon CHCS team Advisory Committee June 15, 2013."

Similar presentations


Ads by Google